GPER1 and diabetic kidney disease: Putting these observations together, we suggest that diabetes-induced perturbations in the GPER-mediated estrogen signaling are implicated in the pathogenesis of diabetic nephropathy; and the proposed molecular mechanism could involve miR-30b-5p downregulation.